Article Text

Download PDFPDF
Pneumocystis jirovecii pneumonia as a complication of etoposide therapy


Two patients receiving oral etoposide therapy developed Pneumocystis jirovecii pneumonia during chemotherapy with significant lymphopenia without corticosteroid use. In this commentary we discuss cellular mechanisms by which etoposide induced CD4+ T lymphocyte dysfunction and reduced survival may lead to predisposition to P. jirovecii infection.

  • malignant disease and immunosuppression
  • infections
  • haematology (incl blood transfusion)
  • pneumonia (infectious disease)

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.